TGF-β1 increases permeability of ciliated airway epithelia via redistribution of claudin 3 from tight junction into cell nuclei.


Journal

Pflugers Archiv : European journal of physiology
ISSN: 1432-2013
Titre abrégé: Pflugers Arch
Pays: Germany
ID NLM: 0154720

Informations de publication

Date de publication:
02 2021
Historique:
received: 13 05 2020
accepted: 03 12 2020
revised: 31 10 2020
pubmed: 3 1 2021
medline: 15 12 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

TGF-β1 is a major mediator of airway tissue remodelling during atopic asthma and affects tight junctions (TJs) of airway epithelia. However, its impact on TJs of ciliated epithelia is sparsely investigated. Herein we elaborated effects of TGF-β1 on TJs of primary human bronchial epithelial cells. We demonstrate that TGF-β1 activates TGF-β1 receptors TGFBR1 and TGFBR2 resulting in ALK5-mediated phosphorylation of SMAD2. We observed that TGFBR1 and -R2 localize specifically on motile cilia. TGF-β1 activated accumulation of phosphorylated SMAD2 (pSMAD2-C) at centrioles of motile cilia and at cell nuclei. This triggered an increase in paracellular permeability via cellular redistribution of claudin 3 (CLDN3) from TJs into cell nuclei followed by disruption of epithelial integrity and formation of epithelial lesions. Only ciliated cells express TGF-β1 receptors; however, nuclear accumulations of pSMAD2-C and CLDN3 redistribution were observed with similar time course in ciliated and non-ciliated cells. In summary, we demonstrate a role of motile cilia in TGF-β1 sensing and showed that TGF-β1 disturbs TJ permeability of conductive airway epithelia by redistributing CLDN3 from TJs into cell nuclei. We conclude that the observed effects contribute to loss of epithelial integrity during atopic asthma.

Identifiants

pubmed: 33386991
doi: 10.1007/s00424-020-02501-2
pii: 10.1007/s00424-020-02501-2
pmc: PMC7835204
doi:

Substances chimiques

CLDN3 protein, human 0
Claudin-3 0
SMAD2 protein, human 0
Smad2 Protein 0
Transforming Growth Factor beta1 0
Receptor, Transforming Growth Factor-beta Type I EC 2.7.11.30
Receptor, Transforming Growth Factor-beta Type II EC 2.7.11.30
TGFBR1 protein, human EC 2.7.11.30
TGFBR2 protein, human EC 2.7.11.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-311

Références

J Endocrinol. 2006 Dec;191(3):525-35
pubmed: 17170211
J Pharmacol Toxicol Methods. 2017 Jul;86:19-27
pubmed: 28259823
Mol Reprod Dev. 2005 Aug;71(4):444-52
pubmed: 15858826
Clin Respir J. 2010 May;4 Suppl 1:15-9
pubmed: 20500605
N Engl J Med. 2019 May 16;380(20):1941-1953
pubmed: 31091375
Biochim Biophys Acta. 2008 Mar;1778(3):631-45
pubmed: 18036336
Innate Immun. 2017 Apr;23(3):276-284
pubmed: 28142299
Semin Cell Dev Biol. 2015 Jun;42:47-57
pubmed: 25951797
Ann N Y Acad Sci. 2009 May;1165:34-43
pubmed: 19538285
Ann N Y Acad Sci. 2017 Oct;1405(1):102-115
pubmed: 28633196
J Biol Chem. 1997 Oct 31;272(44):28107-15
pubmed: 9346966
Oncol Lett. 2018 Jan;15(1):99-108
pubmed: 29285188
Am J Physiol Lung Cell Mol Physiol. 2015 Jun 15;308(12):L1212-23
pubmed: 25888574
Annu Rev Physiol. 2013;75:551-67
pubmed: 23072447
Nature. 2011 Jun 15;474(7351):343-9
pubmed: 21677751
Biochim Biophys Acta. 2014 Sep;1843(9):2079-88
pubmed: 24907662
J Mol Histol. 2016 Jun;47(3):353-63
pubmed: 26956365
PLoS One. 2015 Jun 24;10(6):e0130517
pubmed: 26107373
Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1166-78
pubmed: 12909588
Cell Biol Int. 2005 May;29(5):340-6
pubmed: 15893943
Nat Commun. 2019 Feb 18;10(1):816
pubmed: 30778075
J Mol Biol. 2020 Mar 27;432(7):2405-2427
pubmed: 32142789
Cell Mol Life Sci. 2011 Dec;68(23):3903-18
pubmed: 21533891
Clin Exp Pharmacol Physiol. 2012 Aug;39(8):661-7
pubmed: 21883378
Am J Rhinol Allergy. 2017 Mar 1;31(2):85-92
pubmed: 28452704
Cell Rep. 2013 Jun 27;3(6):1806-14
pubmed: 23746451
Respir Res. 2005 Jun 09;6:56
pubmed: 15946381
Science. 2009 Aug 28;325(5944):1131-4
pubmed: 19628819
Cell. 2003 Jun 13;113(6):685-700
pubmed: 12809600
Respir Res. 2010 May 17;11:59
pubmed: 20478039
Int J Cancer. 2010 Mar 15;126(6):1353-66
pubmed: 19739116
Mol Cell. 2001 Sep;8(3):671-82
pubmed: 11583628
Mol Cancer. 2015 Jun 17;14:120
pubmed: 26081244
J Cell Biol. 2004 Jun 7;165(5):723-34
pubmed: 15184403
Int J Oncol. 2015 Aug;47(2):650-6
pubmed: 26043767
Mol Biol Cell. 2019 Jun 1;30(12):1406-1424
pubmed: 30943107
Front Cell Dev Biol. 2020 Feb 11;8:21
pubmed: 32117962
Science. 1994 Apr 1;264(5155):101-4
pubmed: 8140412
J Biol Chem. 2017 May 19;292(20):8484-8497
pubmed: 28373278
J Immunol. 2007 Jun 15;178(12):7879-89
pubmed: 17548626
Mol Cell Biochem. 2017 Aug;432(1-2):91-98
pubmed: 28316062
Am J Respir Cell Mol Biol. 2016 May;54(5):707-17
pubmed: 26473470
Biophys J. 2004 Jun;86(6):3993-4003
pubmed: 15189895
Cold Spring Harb Perspect Biol. 2016 Sep 01;8(9):
pubmed: 27449815
Nature. 1996 Sep 12;383(6596):168-72
pubmed: 8774881
Respir Res. 2013 Apr 02;14:39
pubmed: 23547562
Cell Signal. 2016 Oct;28(10):1537-44
pubmed: 27424491
Biomolecules. 2020 Mar 23;10(3):
pubmed: 32210029
Am J Respir Crit Care Med. 2000 Dec;162(6):2295-301
pubmed: 11112154
J Clin Invest. 2012 Nov;122(11):4145-59
pubmed: 23041624
J Clin Invest. 2009 Jun;119(6):1429-37
pubmed: 19487819
J Clin Invest. 2005 Jul;115(7):1765-76
pubmed: 15965503
J Immunol. 2005 May 1;174(9):5774-80
pubmed: 15843580
Biochem J. 2015 Jun 15;468(3):449-58
pubmed: 25849148
Annu Rev Physiol. 2006;68:403-29
pubmed: 16460278
Am J Physiol Lung Cell Mol Physiol. 2014 Oct 1;307(7):L524-36
pubmed: 25106430
Tissue Barriers. 2017 Apr 3;5(2):e1327839
pubmed: 28548895
Cytometry A. 2013 Feb;83(2):235-41
pubmed: 23212973
Endocr Relat Cancer. 2015 Oct;22(5):819-30
pubmed: 26219679
Purinergic Signal. 2014 Sep;10(3):487-97
pubmed: 24627191
J Histochem Cytochem. 2009 Mar;57(3):187-95
pubmed: 18955738
J Cell Sci. 2012 Nov 1;125(Pt 21):5051-60
pubmed: 22946048
Int J Med Sci. 2009;6(2):93-101
pubmed: 19305641
Ann N Y Acad Sci. 2012 Jun;1257:175-83
pubmed: 22671604
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1370-1375
pubmed: 29358407
Cold Spring Harb Perspect Biol. 2016 May 02;8(5):
pubmed: 27141051
Methods Mol Med. 2005;107:183-206
pubmed: 15492373
Methods Mol Biol. 2016;1344:63-92
pubmed: 26520118
J Biol Chem. 1997 Oct 31;272(44):27678-85
pubmed: 9346908
EMBO J. 1997 Sep 1;16(17):5353-62
pubmed: 9311995
Oncol Lett. 2015 Jul;10(1):156-162
pubmed: 26170992
Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L363-70
pubmed: 15908476
Int J Mol Sci. 2018 Aug 20;19(8):
pubmed: 30127261
Gastroenterology. 2012 Feb;142(2):305-15
pubmed: 22044670
J Appl Physiol (1985). 2005 Jan;98(1):322-8
pubmed: 15361518
Blood. 1991 Nov 15;78(10):2702-7
pubmed: 1726708

Auteurs

Carolin Schilpp (C)

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Robin Lochbaum (R)

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Peter Braubach (P)

Institute of Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Danny Jonigk (D)

Institute of Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Manfred Frick (M)

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Paul Dietl (P)

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Oliver H Wittekindt (OH)

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany. oliver.witttekindt@uni-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH